CLEVELAND DIAGNOSTICS

cleveland-diagnostics-logo

Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to improve cancer diagnostics. Its solvent interaction analysis technology investigates protein biomarkers at the structural level, providing better and more direct insights regarding the protein origin on the cellular level, thus improving test specificity to the underlying disease process. Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases.

#SimilarOrganizations #People #Financial #Website #More

CLEVELAND DIAGNOSTICS

Social Links:

Industry:
Biotechnology Health Care Health Diagnostics

Founded:
2013-01-01

Address:
Cleveland, Ohio, United States

Country:
United States

Website Url:
http://www.clevelanddx.com

Total Employee:
11+

Status:
Active

Contact:
+1 216 432 2700

Email Addresses:
info@clevelanddx.com

Total Funding:
35.98 M USD

Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS AWS Global Accelerator


Similar Organizations

advanced-cell-diagnostics-logo

Advanced Cell Diagnostics

Advanced Cell Diagnostics is a molecular pathology company developing cell- and tissue-based diagnostic tests for personalized medicine.

disarm-therapeutics-logo

Disarm Therapeutics

Disarm Therapeutics is a biotechnology company developing disease-modifying therapeutics for patients with axonal degeneration.

nanocellect-biomedical-logo

NanoCellect Biomedical

NanoCellect Biomedical is a biotech company developing and commercializing cell analysis and sorting.

stemline-therapeutics-logo

Stemline Therapeutics

Stemline Therapeutics is a clinical stage biopharmaceutical company developing oncology compounds that target cancer stem cells.

Current Employees Featured

arnon-chait_image

Arnon Chait
Arnon Chait President and CEO @ Cleveland Diagnostics
President and CEO

not_available_image

Boris Zaslavsky
Boris Zaslavsky Chief Scientific Officer @ Cleveland Diagnostics
Chief Scientific Officer

bob-rochelle_image

Bob Rochelle
Bob Rochelle Chief Commercial Officer @ Cleveland Diagnostics
Chief Commercial Officer

erich-heise_image

Erich Heise
Erich Heise Associate Director, Business Development @ Cleveland Diagnostics
Associate Director, Business Development
2016-08-23

not_available_image

Jim Canfield
Jim Canfield Senior Vice President Sales @ Cleveland Diagnostics
Senior Vice President Sales
2021-01-01

Founder


arnon-chait_image

Arnon Chait

not_available_image

Boris Zaslavsky

Investors List

lyfe-capital-2_image

LYFE Capital

LYFE Capital investment in Series D - Cleveland Diagnostics

cleveland-clinic_image

Cleveland Clinic

Cleveland Clinic investment in Series D - Cleveland Diagnostics

genomic-health_image

Genomic Health

Genomic Health investment in Convertible Note - Cleveland Diagnostics

Official Site Inspections

http://www.clevelanddx.com

  • Host name: 198.185.159.145
  • IP address: 198.185.159.145
  • Location: New York United States
  • Latitude: 40.7157
  • Longitude: -74
  • Metro Code: 501
  • Timezone: America/New_York
  • Postal: 10013

Loading ...

More informations about "Cleveland Diagnostics"

Cancer Testing - Cleveland Diagnostics

Cleveland Diagnostics was co-founded by the Cleveland Clinic, one of the world’s most highly regarded hospital systems.See details»

Leadership - Cleveland Diagnostics

Arnon Chait, PhD, MBA President & CEO Cleveland Diagnostics. Joseph Rich, JD Senior Director, Governance, Grants and Policies Cleveland Clinic VenturesSee details»

Cleveland Diagnostics - Crunchbase Company Profile …

Contact Email info@clevelanddx.com Phone Number +1 216 432 2700 Cleveland Diagnostics is a commercial-stage diagnostics company developing efficacious, lab-friendly, affordable diagnostics tests using proprietary technology to …See details»

Cleveland Diagnostics Completes $75M Financing to Advance its …

Jan 17, 2024 Media Contact Liz Robinson Account Supervisor at CG Life News@ClevelandDx.com 847-702-8099 Investor Contact David Holmes Gilmartin Group …See details»

ClevelandDx Company Profile 2024: Valuation, Funding …

ClevelandDx General Information Description. Developer of a medical technology designed to detect cancer early when it can be treated and cured. The company's technology evaluates the changes to the structure of the protein biomarker …See details»

Cleveland Diagnostics Completes $75M Financing to Advance its …

CLEVELAND, January 17, 2024--Cleveland Diagnostics Completes $75M Financing to Advance its Early-detection Oncology Testing PlatformSee details»

Cleveland Diagnostics Receives College of American …

May 5, 2021 Visit us at ClevelandDx.com and IsoPSA.com. About the College of American Pathologists. As the world’s largest organization of board-certified pathologists and leading provider of laboratory ...See details»

Cleveland Diagnostics Completes $75M Financing to Advance its …

Jan 16, 2024 Learn more at ClevelandDx.com and IsoPSA.com. About Novo Holdings. Novo Holdings is a holding and investment company that is responsible for managing the assets and …See details»

Cleveland Diagnostics, Inc. Raises Over $19 Million in …

Feb 9, 2021 Cleveland Diagnostics, Inc., a clinical-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, anSee details»

Cleveland Diagnostics Opens New Facility Amid Growing Demand …

CLEVELAND – (June 28, 2023) -- Cleveland Diagnostics, Inc., a commercial-stage biotechnology company developing next-generation diagnostic tests for the early detection of cancers, has …See details»

Cleveland Diagnostics re-ups prostate-specific antigen test push

Aug 27, 2024 This marks the second year for the “A PSA on PSA” campaign, which ClevelandDx started in 2023 to educate patients and their families and caregivers about the …See details»

CME — Cleveland Diagnostics

The opinions expressed are solely those of the faculty and do not reflect those of ClevelandDx. Please refer to clevelanddx.com for complete information. CME Banner. CME Prostate Cancer …See details»

The IsoPSA Test Is Available, and It Could Change the Diagnostic ...

Jul 7, 2020 Questions about the test can be directed to Dr. Klein (kleine@ccf.org) or Bob Rochelle, MBA, Chief Commercial Officer, Cleveland Diagnostics …See details»

Cleveland Diagnostics Opens New Facility Amid Growing Demand …

Jun 28, 2023 Liz Robinson News@ClevelandDx.com 312-997-2436 Release Summary. Cleveland Diagnostics Opens New Facility Amid Growing Demand for IsoPSA® Test. …See details»

Cleveland Diagnostics Receives Support from JobsOhio

Nov 8, 2021 Its portfolio of non-invasive cancer diagnostics will be expanding from prostate cancer to breast cancer and lung cancer, and certain neurological diseases. Visit us at …See details»

Cleveland Diagnostics Opens New Facility Amid Growing Demand …

Jun 29, 2023 Please visit us at ClevelandDx.com. Contacts. Liz Robinson News@ClevelandDx.com 312-997-2436 . 250 First Avenue, Suite 300 Needham, MA 02494 …See details»

Cleveland Diagnostics Closes $75M Private Financing | 360Dx

Jan 17, 2024 NEW YORK — Cleveland Diagnostics said Wednesday that it has closed $75 million in a private financing. The company said it plans to use the funds to support …See details»

NEWS & MEDIA — Cleveland Diagnostics

Eric Klein, MD from the Glickman Urological and Kidney Institute at the Cleveland Clinic speaks about the AUA 2021 Abstract - MP60-03 IsoPSA: Clinical performance of a single parameter, …See details»

Cleveland Diagnostics Presents New Data Supporting the Clinical ...

Sep 14, 2021 Cleveland Diagnostics, Inc. Bob Rochelle Phone: (216) 432-2700, Ext. 2119 Bob.Rochelle@ClevelandDx.com Release Summary IsoPSA demonstrates significant clinical …See details»

linkstock.net © 2022. All rights reserved